MRCY Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Mercury Systems Inc (MRCY) is not a strong buy for a beginner, long-term investor at this time. The stock's technical indicators are weak, with a negative MACD, low RSI, and converging moving averages. Options data shows a bearish sentiment with a low Put-Call Volume Ratio (0.07), and hedge funds are selling heavily. While analysts have raised price targets recently, the company's financial performance is underwhelming, with declining net income, EPS, and gross margin. There are no significant positive catalysts or recent influential purchases to support a strong buy decision.
The MACD is negative and expanding (-0.966), indicating bearish momentum. RSI is at 28.706, suggesting the stock is approaching oversold territory but not yet a clear buy signal. Moving averages are converging, showing no clear trend. Key support is at 76.841, and resistance is at 82.56. The stock is trading close to its support level.
Analysts have raised price targets recently, with Truist and Canaccord highlighting strong execution and robust Q2 earnings. The company is focused on improving working capital and supply chain management.
Hedge funds are selling heavily, with a 387.56% increase in selling activity last quarter. Financial performance is weak, with declining net income (-14.13% YoY), EPS (-16.67% YoY), and gross margin (-1.75% YoY). The MACD and RSI indicate bearish momentum, and there is no recent congress trading data or influential purchases to support a bullish outlook.
In Q2 2026, revenue increased by 4.37% YoY to $232.87 million. However, net income dropped by 14.13% YoY to -$15.1 million, EPS declined by 16.67% YoY to -$0.25, and gross margin fell by 1.75% YoY to 21.87%.
Analyst sentiment is mixed. RBC Capital, Truist, and Canaccord have raised price targets and maintain Buy ratings, citing strong execution and Q2 earnings beat. However, Jefferies lowered its price target to $85 and maintains a Hold rating, citing low-single-digit growth guidance. Goldman Sachs maintains a Sell rating with a $55 price target, highlighting risks in defense margins and elevated valuations.
